A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

The effect of adverse and positive experiences on inflammatory markers in Australian and UK children




TekijätPriest Naomi, Guo Shuaijun, Gondek Dawid, Lacey Rebecca E, Burgner David, Downes Marnie, Slopen Natalie, Goldfeld Sharon, Moreno-Betancur Margarita, Kerr Jessica A, Cahill Stephanie, Wake Melissa, Juonala Markus, Lycett Kate, O'Connor Meredith

KustantajaElsevier Inc.

Julkaisuvuosi2022

JournalBrain, Behavior, & Immunity - Health

Tietokannassa oleva lehden nimiBrain, behavior, & immunity - health

Lehden akronyymiBrain Behav Immun Health

Artikkelin numero100550

Vuosikerta26

ISSN2666-3546

eISSN2666-3546

DOIhttps://doi.org/10.1016/j.bbih.2022.100550

Verkko-osoitehttps://doi.org/10.1016/j.bbih.2022.100550

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/177720524


Tiivistelmä

BACKGROUND

The relationship between childhood adversity and inflammation is well-established. Examination of positive experiences can provide a more complete understanding of intervention opportunities. We investigated associations of adverse and positive experiences, and their intersection, with inflammation in children and adolescents.

METHODS

Data sources: Longitudinal Study of Australian Children (LSAC; N = 1237) and Avon Longitudinal Study of Parents and Children (ALSPAC; N = 3488). Exposures: Adverse and positive experiences assessed repeatedly (LSAC: 0-11 years; ALSPAC: 0-15 years). Outcomes: Inflammation quantified by high sensitivity C-reactive protein (hsCRP) and glycoprotein acetyls (GlycA) (LSAC: 11-12 years; ALSPAC: 15.5 years). Analyses: Linear regression on the log-transformed outcomes estimated the relative difference in inflammatory markers with adverse/positive experiences, adjusting for socio-demographics and concurrent positive/adverse experiences, respectively.

RESULTS

Most associations were in the expected direction but differed in magnitude by exposure, outcome and cohort. Across both cohorts, adverse experiences were associated with up to 7.3% higher hsCRP (95% CI: -18.6%, 33.2%) and up to 2.0% higher GlycA (95% CI: 0.5%, 3.5%); while positive experiences were associated with up to 22.1% lower hsCRP (95% CI: -49.0%, 4.7%) and 1.3% lower GlycA (95% CI: -2.7%, 0.2%). In LSAC, the beneficial effect of positive experiences on inflammation was more pronounced among those with fewer concurrent adverse experiences.

CONCLUSION

Across two cohorts, we found small but directionally consistent associations between adverse experiences and higher inflammation, and positive experiences and lower inflammation, particularly for GlycA. Future research should give further consideration to positive experiences to complement the current focus on adversity and inform the design and evaluation of early life interventions.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-27-03 at 21:55